Need help finding what you are looking for?
Contact Us
PUBLISHER: 360iResearch | PRODUCT CODE: 1471211
PUBLISHER: 360iResearch | PRODUCT CODE: 1471211
Primary Cells Market by Origin (Animal Primary Cells, Human Primary Cells), Cell Type (Dermatocytes, Gastrointestinal Cells, Heart Cells), End-User - Global Forecast 2024-2030
PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
[195 Pages Report] The Primary Cells Market size was estimated at USD 1.43 billion in 2023 and expected to reach USD 1.60 billion in 2024, at a CAGR 12.10% to reach USD 3.18 billion by 2030.
Primary cells are the fundamental building blocks of tissues and organs and exhibit natural biological behavior similar to their origin, making them an essential tool in various scientific applications. Increased investment in regenerative medicine and cell-based research drives primary cells' need to develop innovative therapeutic solutions. Technological advancements such as CRISPR gene-editing techniques have expanded primary cell usage by offering more precise manipulation tools for targeted therapies. However, primary cells may exhibit donor-to-donor variability due to genetic and environmental factors influencing their biology, potentially limiting their reproducibility in research settings. Nevertheless, the increasing number of life sciences collaborations between academic institutions, research laboratories, and biopharmaceutical manufacturers is expected to contribute to exploring primary cell-based therapies.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.43 billion |
| Estimated Year [2024] | USD 1.60 billion |
| Forecast Year [2030] | USD 3.18 billion |
| CAGR (%) | 12.10% |
Origin: Increasing preference for human primary cells for accurate representations of human cellular responses
Animal primary cells are isolated directly from animal tissues and retain many of their original physiological properties, making them a valuable tool for in vitro studies and preclinical research. Researchers commonly use animal primary cells to study biological processes, screen drugs, and develop new disease therapies. The advantages of using animal primary cells include ease of availability, low cost compared to human primary cells, and the ability to model species-specific responses to treatments. Human primary cells are derived directly from human tissues and maintain many characteristics similar to their origin tissue. They are essential for understanding human biology, drug discovery, pathology, toxicity testing, and regenerative medicine applications. Human primary cell cultures provide more accurate representations of human cellular responses than immortalized cell lines or animal models. Human primary cells are often preferred for applications requiring a higher biological relevance, especially when studying human-specific diseases or developing patient therapies.
Cell Type: Rising adoption of dermatocytes in drug development and toxicity testing
Dermatocytes are essential for researchers studying skin biology, wound healing, and dermatological disorders. They are widely used in drug development and toxicity testing. Gastrointestinal cells encompass a variety of cell types found in the gastrointestinal tract and are vital for research on gut health, nutrient absorption, and digestive disorders. Cardiomyocytes or heart cells are central to cardiovascular research involving cardiac development, function, and disease modeling. Hematopoietic stem cells (HSCs) give rise to all blood cell types and have diverse applications in regenerative medicine & transplantation therapies for hematological disorders such as leukemia or lymphoma. Primary hepatocytes are crucial to research involving liver function, metabolism, and toxicity testing of pharmaceuticals. Pulmonary research relies heavily on primary lung cells for studying respiratory diseases such as asthma, COPD, or lung cancer. Musculoskeletal cells consist of bone, cartilage, and muscle-forming cells and are imperative in musculoskeletal disorder studies, regenerative medicine applications & tissue engineering solutions. Kidney or renal primary cells offer insightful models for nephrology research, including kidney disease progression & drug toxicity assessment on renal functions.
End-User: Proliferating use of primary cells in life science companies to ensure accurate results during experimentation
Life science companies, including biotechnology, pharmaceutical, and medical device industries, heavily invest in research and development activities. These companies require primary cells for drug discovery, toxicity testing, cell therapy development, regenerative medicine applications, and manufacturing biological products. These companies involve high-quality primary cells with well-characterized phenotypes to ensure accurate results during experimentation. Research institutes encompass academic institutions and government-funded laboratories focused on understanding fundamental biological processes and disease mechanisms. Primary cells are essential to their research efforts due to their relevance as model systems in studying cellular processes or responses under various experimental conditions. The preference of research institutes revolves around the availability of diverse primary cell types, sourced ethically and with proper documentation, to ensure reproducibility across different laboratories.
Regional Insights
Americas region showcases significant growth primarily due to the presence of well-established biotechnology and pharmaceutical industries in countries such as the United States and Canada. The rapid adoption of advanced technologies in cell culture methodologies and increasing investments in research & development activities contribute to this region's strong performance. Furthermore, several government initiatives aimed at promoting novel therapies using primary cells have spurred growth in this sector. In the APAC region, countries such as China and India are experiencing considerable expansion of their biopharmaceutical sectors. This is attributed to factors such as a growing elderly population with a higher prevalence of chronic diseases requiring innovative treatment options, increased healthcare expenditure, and a greater focus on research & development activities. As a result, there has been a surge in demand for primary cells within this region. Additionally, Japan boasts a strong presence in regenerative medicine research, which has led to increased utilization of primary cells for therapeutic purposes. Europe is experiencing significant growth with its robust R&D framework supported by substantial investments from both governmental organizations and private entities. Countries such as Germany, France, Italy, UK, Spain, and the Netherlands have all contributed significantly through their respective biotechnology pharmaceutical industries, shaping up an overall progressive scenario within the EMEA region.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Primary Cells Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Primary Cells Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Primary Cells Market, highlighting leading vendors and their innovative profiles. These include Biopredic International, Corning Incorporated, Danaher Corporation, FUJIFILM Irvine Scientific, Inc., Lonza AG, PromoCell GmbH, Reachbio LLC, Sciencell Research Laboratories, Inc., Sekisui Xenotech, LLC, Stem Cell Technologies, Inc., StemExpress, LLC, The Bio Convergence Company, The Merck Group, Thermo Fisher Scientific, Inc., and Zenbio, Inc..
Market Segmentation & Coverage
This research report categorizes the Primary Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Origin
- Animal Primary Cells
- Human Primary Cells
- Cell Type
- Dermatocytes
- Gastrointestinal Cells
- Heart Cells
- Hematopoietic Cells
- Hepatocytes
- Cryopreserved Hepatocytes
- Fresh Hepatocytes
- Lung Cells
- Musculoskeletal Cells
- Renal Cells
- End-User
- Life Science Companies
- Research Institutes
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Americas
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Primary Cells Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Primary Cells Market?
3. What are the technology trends and regulatory frameworks in the Primary Cells Market?
4. What is the market share of the leading vendors in the Primary Cells Market?
5. Which modes and strategic moves are suitable for entering the Primary Cells Market?
Product Code: MRR-4F4C36263622
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing acceptance in drug screening and cell based assays
- 5.1.1.2. Advantages of primary human cells over other existing methods
- 5.1.1.3. Growing focus on monoclonal antibodies and personalized medicine
- 5.1.2. Restraints
- 5.1.2.1. Common cell culture problems such as contamination
- 5.1.3. Opportunities
- 5.1.3.1. Expanding biotechnology and biopharmaceutical industries
- 5.1.3.2. Advancements in biomedical research using primary cells
- 5.1.4. Challenges
- 5.1.4.1. Ethical issues in cell biology research field
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Origin: Increasing preference for human primary cells for accurate representations of human cellular responses
- 5.2.2. Cell Type: Rising adoption of dermatocytes in drug development and toxicity testing
- 5.2.3. End-User: Proliferating use of primary cells in life science companies to ensure accurate results during experimentation
- 5.3. Market Disruption Analysis
- 5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
- 5.5. Value Chain & Critical Path Analysis
- 5.6. Pricing Analysis
- 5.7. Technology Analysis
- 5.8. Patent Analysis
- 5.9. Trade Analysis
- 5.10. Regulatory Framework Analysis
6. Primary Cells Market, by Origin
- 6.1. Introduction
- 6.2. Animal Primary Cells
- 6.3. Human Primary Cells
7. Primary Cells Market, by Cell Type
- 7.1. Introduction
- 7.2. Dermatocytes
- 7.3. Gastrointestinal Cells
- 7.4. Heart Cells
- 7.5. Hematopoietic Cells
- 7.6. Hepatocytes
- 7.7. Lung Cells
- 7.8. Musculoskeletal Cells
- 7.9. Renal Cells
8. Primary Cells Market, by End-User
- 8.1. Introduction
- 8.2. Life Science Companies
- 8.3. Research Institutes
9. Americas Primary Cells Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Primary Cells Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Primary Cells Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. CN Bio and LifeNet Health LifeSciences Partner to Supply Validated Primary Human Cells for Microphysiological Systems
- 12.3.2. AnaBios Acquires Cell Systems, Expands Human Cell Portfolio for Drug Discovery
- 12.3.3. Human Cell Design Launches Endoc-BH5, an Advanced Human Beta Cell Model enabling New Discoveries in Type 1 and 2 Diabetes Research
- 12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.2. Key Product Portfolio
Product Code: MRR-4F4C36263622
LIST OF FIGURES
- FIGURE 1. PRIMARY CELLS MARKET RESEARCH PROCESS
- FIGURE 2. PRIMARY CELLS MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. PRIMARY CELLS MARKET DYNAMICS
- FIGURE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2023 VS 2030 (%)
- FIGURE 8. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
- FIGURE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 22. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. PRIMARY CELLS MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2023 (USD MILLION)
- TABLE 4. GLOBAL PRIMARY CELLS MARKET SIZE, 2024-2030 (USD MILLION)
- TABLE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
- TABLE 6. GLOBAL PRIMARY CELLS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
- TABLE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 8. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 11. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 12. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 13. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 14. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 15. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY REGION, 2018-2023 (USD MILLION)
- TABLE 16. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY REGION, 2024-2030 (USD MILLION)
- TABLE 17. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 18. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 19. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 20. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 21. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 22. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 23. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY REGION, 2018-2023 (USD MILLION)
- TABLE 24. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY REGION, 2024-2030 (USD MILLION)
- TABLE 25. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 26. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 27. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY REGION, 2018-2023 (USD MILLION)
- TABLE 28. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY REGION, 2024-2030 (USD MILLION)
- TABLE 29. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY REGION, 2018-2023 (USD MILLION)
- TABLE 30. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY REGION, 2024-2030 (USD MILLION)
- TABLE 31. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 32. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 33. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 34. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 35. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY REGION, 2018-2023 (USD MILLION)
- TABLE 36. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY REGION, 2024-2030 (USD MILLION)
- TABLE 37. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 38. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 39. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
- TABLE 40. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
- TABLE 41. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
- TABLE 42. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
- TABLE 43. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 44. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 45. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 46. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 47. AMERICAS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 48. AMERICAS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 49. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 50. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 51. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
- TABLE 52. AMERICAS PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 53. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 54. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 55. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 56. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 57. ARGENTINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 58. ARGENTINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 59. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 60. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 61. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 62. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 63. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 64. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 65. BRAZIL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 66. BRAZIL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 67. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 68. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 69. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 70. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 71. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 72. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 73. CANADA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 74. CANADA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 75. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 76. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 77. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 78. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 79. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 80. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 81. MEXICO PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 82. MEXICO PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 83. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 84. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 85. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 86. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 87. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 88. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 89. UNITED STATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 90. UNITED STATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 91. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 92. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 93. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
- TABLE 94. UNITED STATES PRIMARY CELLS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
- TABLE 95. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 96. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 97. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 98. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 99. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 100. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 101. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 102. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 103. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
- TABLE 104. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 105. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 106. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 107. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 108. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 109. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 110. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 111. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 112. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 113. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 114. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 115. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 116. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 117. CHINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 118. CHINA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 119. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 120. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 121. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 122. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 123. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 124. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 125. INDIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 126. INDIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 127. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 128. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 129. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 130. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 131. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 132. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 133. INDONESIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 134. INDONESIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 135. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 136. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 137. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 138. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 139. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 140. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 141. JAPAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 142. JAPAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 143. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 144. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 145. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 146. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 147. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 148. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 149. MALAYSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 150. MALAYSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 151. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 152. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 153. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 154. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 155. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 156. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 157. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 158. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 159. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 160. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 161. SINGAPORE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 162. SINGAPORE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 163. SINGAPORE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 164. SINGAPORE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 165. SINGAPORE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 166. SINGAPORE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 167. SINGAPORE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 168. SINGAPORE PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 169. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 170. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 171. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 172. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 173. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 174. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 175. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 176. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 177. TAIWAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 178. TAIWAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 179. TAIWAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 180. TAIWAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 181. TAIWAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 182. TAIWAN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 183. TAIWAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 184. TAIWAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 185. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 186. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 187. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 188. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 189. THAILAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 190. THAILAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 191. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 192. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 193. VIETNAM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 194. VIETNAM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 195. VIETNAM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 196. VIETNAM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 197. VIETNAM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 198. VIETNAM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 199. VIETNAM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 200. VIETNAM PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 201. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 202. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 203. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 204. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 205. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 206. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 207. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 208. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 209. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
- TABLE 210. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
- TABLE 211. DENMARK PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 212. DENMARK PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 213. DENMARK PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 214. DENMARK PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 215. DENMARK PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 216. DENMARK PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 217. DENMARK PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 218. DENMARK PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 219. EGYPT PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 220. EGYPT PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 221. EGYPT PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 222. EGYPT PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 223. EGYPT PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 224. EGYPT PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 225. EGYPT PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 226. EGYPT PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 227. FINLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 228. FINLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 229. FINLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 230. FINLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 231. FINLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 232. FINLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 233. FINLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 234. FINLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 235. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 236. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 237. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 238. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 239. FRANCE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 240. FRANCE PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 241. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 242. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 243. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 244. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 245. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 246. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 247. GERMANY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 248. GERMANY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 249. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 250. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 251. ISRAEL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 252. ISRAEL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 253. ISRAEL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 254. ISRAEL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 255. ISRAEL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 256. ISRAEL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 257. ISRAEL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 258. ISRAEL PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 259. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 260. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 261. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 262. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 263. ITALY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 264. ITALY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 265. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 266. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 267. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 268. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 269. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 270. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 271. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 272. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 273. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 274. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 275. NIGERIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 276. NIGERIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 277. NIGERIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 278. NIGERIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 279. NIGERIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 280. NIGERIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 281. NIGERIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 282. NIGERIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 283. NORWAY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 284. NORWAY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 285. NORWAY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 286. NORWAY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 287. NORWAY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 288. NORWAY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 289. NORWAY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 290. NORWAY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 291. POLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 292. POLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 293. POLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 294. POLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 295. POLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 296. POLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 297. POLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 298. POLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 299. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 300. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 301. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 302. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 303. QATAR PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 304. QATAR PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 305. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 306. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 307. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 308. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 309. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 310. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 311. RUSSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 312. RUSSIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 313. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 314. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 315. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 316. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 317. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 318. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 319. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 320. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 321. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 322. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 323. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 324. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 325. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 326. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 327. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 328. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 329. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 330. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 331. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 332. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 333. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 334. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 335. SPAIN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 336. SPAIN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 337. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 338. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 339. SWEDEN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 340. SWEDEN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 341. SWEDEN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 342. SWEDEN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 343. SWEDEN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 344. SWEDEN PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 345. SWEDEN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 346. SWEDEN PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 347. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 348. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 349. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 350. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 351. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 352. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 353. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 354. SWITZERLAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 355. TURKEY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 356. TURKEY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 357. TURKEY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 358. TURKEY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 359. TURKEY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 360. TURKEY PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 361. TURKEY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 362. TURKEY PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 363. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 364. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 365. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 366. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 367. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 368. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 369. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 370. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 371. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2023 (USD MILLION)
- TABLE 372. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2024-2030 (USD MILLION)
- TABLE 373. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
- TABLE 374. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
- TABLE 375. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2018-2023 (USD MILLION)
- TABLE 376. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2024-2030 (USD MILLION)
- TABLE 377. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
- TABLE 378. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
- TABLE 379. PRIMARY CELLS MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 380. PRIMARY CELLS MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.